NovaBridge Biosciences
Giva
first-line treatment of gastric cancer
Countdown
177days
FDA decision · ~ Dec 31, 2026 estimated
What's at stake
An FDA complete response letter on Giva for first-line treatment of gastric cancer is in focus around ~ Dec 31, 2026.
Primary source
· SEC 6-K
verified 13h ago
“Giva Complete Phase 2 study for 1L treatment of GEA in combo with chemo + PD-1 YE26”